238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.47%
Revenue growth under 50% of BIDU's 26.21%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.04%
Gross profit growth under 50% of BIDU's 31.54%. Michael Burry would be concerned about a severe competitive disadvantage.
3.48%
EBIT growth below 50% of BIDU's 49.91%. Michael Burry would suspect deeper competitive or cost structure issues.
3.48%
Operating income growth under 50% of BIDU's 49.91%. Michael Burry would be concerned about deeper cost or sales issues.
-2.93%
Negative net income growth while BIDU stands at 39.90%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.85%
Negative EPS growth while BIDU is at 40.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
0.38%
Share count expansion well above BIDU's 0.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.17%
Diluted share count expanding well above BIDU's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
28.15%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
45.70%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
1743.84%
10Y revenue/share CAGR under 50% of BIDU's 12749.51%. Michael Burry would suspect a lasting competitive disadvantage.
170.35%
5Y revenue/share CAGR under 50% of BIDU's 977.20%. Michael Burry would suspect a significant competitive gap or product weakness.
68.74%
3Y revenue/share CAGR under 50% of BIDU's 249.34%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
2693.48%
OCF/share CAGR of 2693.48% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
227.25%
OCF/share CAGR of 227.25% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
52.64%
3Y OCF/share CAGR of 52.64% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
3329.71%
Below 50% of BIDU's 37053.40%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
111.18%
Below 50% of BIDU's 812.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
27.70%
Below 50% of BIDU's 116.21%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
7518.50%
Equity/share CAGR of 7518.50% while BIDU is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
183.61%
Below 50% of BIDU's 1062.19%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
75.80%
Below 50% of BIDU's 295.31%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.31%
AR growth is negative/stable vs. BIDU's 23.34%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-13.06%
Inventory is declining while BIDU stands at 31.12%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.36%
Asset growth well under 50% of BIDU's 16.42%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.01%
Under 50% of BIDU's 9.46%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-16.05%
We’re deleveraging while BIDU stands at 34.60%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.27%
R&D dropping or stable vs. BIDU's 36.08%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.95%
SG&A growth well above BIDU's 6.97%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.